Efficacy and toxicity of midostaurin with idarubicin and cytarabine induction in <i>FLT3</I>-mutated acute myeloid leukemia-Reference-Cited by-同舟云学术

Efficacy and toxicity of midostaurin with idarubicin and cytarabine induction in <i>FLT3</I>-mutated acute myeloid leukemia

Published:2023-06-22 Issue:12 Volume:108 Page:3460-3463
ISSN:1592-8721
Container-title:Haematologica
language:
Short-container-title:haematol

Author:

Lee Julia S.,Wagner Charlotte B.,Prelewicz Stacy,Kurish Heena P.,Walchack Robert,Cenin Danielle A.,Patel Seema,Lo Mimi,Schlafer Danielle,Li Belinda K.T.,Donald Harvey III R.,Wasef Bestis,Ying Jian,Kovacsovics Tibor

Publisher

Ferrata Storti Foundation (Haematologica)

Subject

Hematology

Reference9 articles.

1. National Comprehensive Cancer Network. Acute myeloid leukemia (Version 3.2023). 2023. Publisher Full Text|

2. Stone RM, Mandrekar SJ, Sanford BL. Midostaurin plus chemotherapy for acute myeloid leukemia with a FLT3 mutation. N Engl J Med. 2017; 377(5):454-464.

3. Burnett AK, Russell NH, Hills RK. United Kingdom National Cancer Research Institute Acute Myeloid Leukemia Study Group. Higher daunorubicin exposure benefits FLT3 mutated acute myeloid leukemia. Blood. 2016; 128(3):449-452.

4. Choi EJ, Lee JH, Lee JH. Comparison of anthracyclines used for induction chemotherapy in patients with FLT3-ITDmutated acute myeloid leukemia. Leuk Res. 2018; 68:51-56.

5. Luskin MR, Lee JW, Fernandez HF. Benefit of high-dose daunorubicin in AML induction extends across cytogenetic and molecular groups. Blood. 2016; 127(12):1551-1558.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Idarubicin and cytarabine with and without midostaurin for FLT3-mutated acute myeloid leukemia;Leukemia & Lymphoma;2024-07-07

2. Venetoclax Combination Treatment of Acute Myeloid Leukemia in Adolescents and Young Adult Patients;Journal of Clinical Medicine;2024-04-01